Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study
Summary Background Hyaluronic acid (HA) fillers and poly‐L‐lactic acid (PLA) fillers are frequently used to correct facial wrinkles. Aim To compare the efficacy and safety of a novel injectable poly‐L‐lactic acid (PLA) filler and a well‐studied biphasic HA filler for the treatment of moderate to sev...
Saved in:
Published in | Clinical and experimental dermatology Vol. 40; no. 2; pp. 129 - 135 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.03.2015
Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
Background
Hyaluronic acid (HA) fillers and poly‐L‐lactic acid (PLA) fillers are frequently used to correct facial wrinkles.
Aim
To compare the efficacy and safety of a novel injectable poly‐L‐lactic acid (PLA) filler and a well‐studied biphasic HA filler for the treatment of moderate to severe nasolabial folds.
Methods
In this multicentre, randomized, evaluator‐blinded, comparative study, subjects were randomized for injections with PLA or HA into both nasolabial folds. Efficacy was determined by calculating the change in Wrinkle Severity Rating Scale (WSRS) relative to baseline. Local safety was assessed by reported adverse events.
Results
At week 24, mean improvement in WSRS from baseline was 2.09 ± 0.68 for the PLA side and 1.54 ± 0.65 for the HA side. Both injections were well tolerated, and the adverse reactions were mild and transient in most cases.
Conclusions
PLA provides noninferior efficacy compared with HA 6 months after being used to treat moderate to severe nasolabial folds. |
---|---|
AbstractList | Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles.
To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of moderate to severe nasolabial folds.
In this multicentre, randomized, evaluator-blinded, comparative study, subjects were randomized for injections with PLA or HA into both nasolabial folds. Efficacy was determined by calculating the change in Wrinkle Severity Rating Scale (WSRS) relative to baseline. Local safety was assessed by reported adverse events.
At week 24, mean improvement in WSRS from baseline was 2.09 ± 0.68 for the PLA side and 1.54 ± 0.65 for the HA side. Both injections were well tolerated, and the adverse reactions were mild and transient in most cases.
PLA provides noninferior efficacy compared with HA 6 months after being used to treat moderate to severe nasolabial folds. Summary Background Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. Aim To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of moderate to severe nasolabial folds. Methods In this multicentre, randomized, evaluator-blinded, comparative study, subjects were randomized for injections with PLA or HA into both nasolabial folds. Efficacy was determined by calculating the change in Wrinkle Severity Rating Scale (WSRS) relative to baseline. Local safety was assessed by reported adverse events. Results At week 24, mean improvement in WSRS from baseline was 2.09 ± 0.68 for the PLA side and 1.54 ± 0.65 for the HA side. Both injections were well tolerated, and the adverse reactions were mild and transient in most cases. Conclusions PLA provides noninferior efficacy compared with HA 6 months after being used to treat moderate to severe nasolabial folds. Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles.BACKGROUNDHyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles.To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of moderate to severe nasolabial folds.AIMTo compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of moderate to severe nasolabial folds.In this multicentre, randomized, evaluator-blinded, comparative study, subjects were randomized for injections with PLA or HA into both nasolabial folds. Efficacy was determined by calculating the change in Wrinkle Severity Rating Scale (WSRS) relative to baseline. Local safety was assessed by reported adverse events.METHODSIn this multicentre, randomized, evaluator-blinded, comparative study, subjects were randomized for injections with PLA or HA into both nasolabial folds. Efficacy was determined by calculating the change in Wrinkle Severity Rating Scale (WSRS) relative to baseline. Local safety was assessed by reported adverse events.At week 24, mean improvement in WSRS from baseline was 2.09 ± 0.68 for the PLA side and 1.54 ± 0.65 for the HA side. Both injections were well tolerated, and the adverse reactions were mild and transient in most cases.RESULTSAt week 24, mean improvement in WSRS from baseline was 2.09 ± 0.68 for the PLA side and 1.54 ± 0.65 for the HA side. Both injections were well tolerated, and the adverse reactions were mild and transient in most cases.PLA provides noninferior efficacy compared with HA 6 months after being used to treat moderate to severe nasolabial folds.CONCLUSIONSPLA provides noninferior efficacy compared with HA 6 months after being used to treat moderate to severe nasolabial folds. Summary Background Hyaluronic acid (HA) fillers and poly‐L‐lactic acid (PLA) fillers are frequently used to correct facial wrinkles. Aim To compare the efficacy and safety of a novel injectable poly‐L‐lactic acid (PLA) filler and a well‐studied biphasic HA filler for the treatment of moderate to severe nasolabial folds. Methods In this multicentre, randomized, evaluator‐blinded, comparative study, subjects were randomized for injections with PLA or HA into both nasolabial folds. Efficacy was determined by calculating the change in Wrinkle Severity Rating Scale (WSRS) relative to baseline. Local safety was assessed by reported adverse events. Results At week 24, mean improvement in WSRS from baseline was 2.09 ± 0.68 for the PLA side and 1.54 ± 0.65 for the HA side. Both injections were well tolerated, and the adverse reactions were mild and transient in most cases. Conclusions PLA provides noninferior efficacy compared with HA 6 months after being used to treat moderate to severe nasolabial folds. |
Author | Lee, Y. Won, C. H. Hyun, M. Y. No, Y. A. Kim, M. N. Hong, C. K. Chang, S. E. Yoo, K. H. Kim, B. J. |
Author_xml | – sequence: 1 givenname: M. Y. surname: Hyun fullname: Hyun, M. Y. organization: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea – sequence: 2 givenname: Y. surname: Lee fullname: Lee, Y. organization: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea – sequence: 3 givenname: Y. A. surname: No fullname: No, Y. A. organization: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea – sequence: 4 givenname: K. H. surname: Yoo fullname: Yoo, K. H. organization: Department of Dermatology, Catholic Kwandong University International ST.Mary's Hospital, Incheon, South Korea – sequence: 5 givenname: M. N. surname: Kim fullname: Kim, M. N. organization: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea – sequence: 6 givenname: C. K. surname: Hong fullname: Hong, C. K. organization: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea – sequence: 7 givenname: S. E. surname: Chang fullname: Chang, S. E. organization: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 8 givenname: C. H. surname: Won fullname: Won, C. H. organization: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 9 givenname: B. J. surname: Kim fullname: Kim, B. J. email: : Dr Beom Joon Kim, Department of Dermatology, Chung-Ang University Hospital, 224-1 Heukseok-dong, Dongjak-gu, Seoul 156-755, Korea, beomjoon@unitel.co.kr organization: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25319932$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctuFDEQRS0URB6w4AeQJTYg0Um7Hbvb2aFhEpBGEPEQS8uPsuLB0x7s7oTmm_hIPMwMiwi8sVR17q1S3WN00MceEHpK6lNS3pkBe0qacyEeoCNCOauahtYH6KimdVtxQbtDdJzzsq4JJS17hA4bRokQtDlCv-bOeaPMhFVvcVYOhglHh32_BDP42OM7P9zgdQxTtaiCKjWDlfEWm7haqwR2C9xMKowp9vuui6kQKe1MimOvcgxKexVKM9gLrHAqM-PK_wT7CsNtMVBDTJUOvreb0naCGvwt4DyMdnqMHjoVMjzZ_Sfoy-X88-xttfhw9W72elEZKoioCG8Vc6wRNbPUUao1d0YY4MKC1o51nDIBjW5t14Ghje5szYgWXNMiPAd6gl5sfdcpfh8hD3Lls4EQVA9xzJJw1pZL1qQp6PN76DKOqS_bbShWcugYLdSzHTXqFVi5Tn6l0iT3ORTgbAuYFHNO4KTxg9qcbkjKB0lquUlalqTln6SL4uU9xd70X-zO_c4HmP4Pytn8zV5RbRU-D_Djr0Klb5K3tGXy6_sr-fETu55xfi0v6W8mCcjx |
CODEN | CEDEDE |
CitedBy_id | crossref_primary_10_1097_DSS_0000000000004195 crossref_primary_10_1186_s12886_023_02821_8 crossref_primary_10_1038_ijir_2017_10 crossref_primary_10_14730_aaps_2019_01977 crossref_primary_10_1007_s00266_024_04543_8 crossref_primary_10_1097_MS9_0000000000001094 crossref_primary_10_12968_joan_2024_0042 crossref_primary_10_1007_s00266_024_04098_8 crossref_primary_10_25056_JCM_2023_7_2_88 crossref_primary_10_1007_s00266_024_03889_3 crossref_primary_10_1039_D1BM00516B crossref_primary_10_1097_DSS_0000000000003627 crossref_primary_10_1007_s00266_021_02439_5 crossref_primary_10_1097_GOX_0000000000002829 crossref_primary_10_1111_jocd_12175 crossref_primary_10_1111_ced_14085 crossref_primary_10_1111_jocd_14461 crossref_primary_10_2319_100317_665_1 crossref_primary_10_1016_j_jsxm_2019_01_310 crossref_primary_10_3390_ijms24097986 crossref_primary_10_1002_lsm_23719 crossref_primary_10_1093_asj_sjae180 |
Cites_doi | 10.1007/s00266-003-3022-1 10.1111/j.1600-0714.2004.00194.x 10.2310/6350.2005.31245 10.1159/000087608 10.1002/jbm.820270904 10.1097/01.prs.0000234612.20611.5a 10.1097/00005537-200110000-00005 10.1055/s-0029-1220648 10.1080/14764170701840074 10.2310/6350.2005.31246 10.3109/14764172.2011.571699 10.1055/s-0032-1305786 10.1007/s00266-004-0113-6 10.1016/S0891-8422(23)00954-0 10.1016/j.jaad.2004.08.056 10.1111/j.1529-8019.2006.00069.x 10.1002/jbm.820070204 10.1111/j.1468-1293.2004.00190.x 10.1055/s-2004-861758 |
ContentType | Journal Article |
Copyright | 2014 British Association of Dermatologists 2014 British Association of Dermatologists. Copyright © 2015 British Association of Dermatologists |
Copyright_xml | – notice: 2014 British Association of Dermatologists – notice: 2014 British Association of Dermatologists. – notice: Copyright © 2015 British Association of Dermatologists |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 |
DOI | 10.1111/ced.12499 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2230 |
EndPage | 135 |
ExternalDocumentID | 3592047841 25319932 10_1111_ced_12499 CED12499 ark_67375_WNG_RS5PC66P_F |
Genre | article Randomized Controlled Trial Journal Article Comparative Study |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29B 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 5WD 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AABZA AACZT AAESR AAEVG AAHHS AAONW AAPGJ AAPXW AARHZ AASGY AAUAY AAVAP AAWDT AAXRX AAZKR ABCQN ABCUV ABDBF ABEJV ABEML ABJNI ABNHQ ABPTD ABPVW ABQNK ABWST ABXGK ABXVV ACAHQ ACBWZ ACCFJ ACCZN ACFRR ACGFS ACMXC ACPOU ACPRK ACSCC ACUTJ ACXBN ACXQS ACZBC ADBBV ADEOM ADIPN ADIZJ ADKYN ADMGS ADOZA ADQBN ADVEK ADXAS ADZMN ADZOD AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFFNX AFGKR AFPWT AFYAG AFZJQ AGMDO AGQXC AGUTN AHEFC AHMBA AIACR AIURR AIWBW AJAOE AJBDE AJEEA ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB APJGH ASPBG ATGXG ATUGU AVNTJ AVWKF AZBYB AZFZN AZVAB BAFTC BCRHZ BDRZF BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBB EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X H13 HF~ HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO KOP L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OAUYM OCZFY OIG OJZSN OPAEJ OVD OWPYF P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL ROX RX1 SUPJJ SV3 TEORI TMA TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AANHP ABDFA ACRPL ACUHS ACYXJ ADNMO ADVOB AHMMS AAYXX ABGNP ABPQP ABVGC ACVCV ADMTO ADNBA AEMQT AFFQV AFXAL AGORE AGQPQ AHGBF AJBYB AJDVS AJNCP ALXQX CITATION OBFPC CGR CUY CVF ECM EIF NPM 7T5 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3919-167a5f52905d3f33bb6fc9ce69debbf586359e2b7d88ec32b8d051b96b37a54e3 |
IEDL.DBID | DR2 |
ISSN | 0307-6938 1365-2230 |
IngestDate | Fri Jul 11 15:58:13 EDT 2025 Fri Jul 25 08:33:01 EDT 2025 Thu Apr 03 07:08:26 EDT 2025 Tue Jul 01 03:09:02 EDT 2025 Thu Apr 24 23:00:08 EDT 2025 Wed Jan 22 16:29:58 EST 2025 Wed Oct 30 09:52:26 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | http://doi.wiley.com/10.1002/tdm_license_1.1 2014 British Association of Dermatologists. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3919-167a5f52905d3f33bb6fc9ce69debbf586359e2b7d88ec32b8d051b96b37a54e3 |
Notes | istex:891EAA9C31E77A15158CC0C159FF9CE412E31D9F ark:/67375/WNG-RS5PC66P-F ArticleID:CED12499 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
PMID | 25319932 |
PQID | 1655230853 |
PQPubID | 4964 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1657317012 proquest_journals_1655230853 pubmed_primary_25319932 crossref_citationtrail_10_1111_ced_12499 crossref_primary_10_1111_ced_12499 wiley_primary_10_1111_ced_12499_CED12499 istex_primary_ark_67375_WNG_RS5PC66P_F |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-03 March 2015 2015-03-00 2015-Mar 20150301 |
PublicationDateYYYYMMDD | 2015-03-01 |
PublicationDate_xml | – month: 03 year: 2015 text: 2015-03 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Clinical and experimental dermatology |
PublicationTitleAlternate | Clin Exp Dermatol |
PublicationYear | 2015 |
Publisher | Blackwell Publishing Ltd Oxford University Press |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Oxford University Press |
References | Rotunda AM, Narins RS. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther 2006; 19: 151-8. Rao J, Chi GC, Goldman MP. Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: hylaform versus Restylane. Dermatol Surg 2005; 31: 1587-90. Gogolewski S, Jovanovic M, Perren SM et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48. Nast A, Reytan N, Hartmann V, Pathirana D et al. Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study. Dermatol Surg 2011; 37: 768-75. Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS. Applications of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 1995; 12: 475-95. Rzany B, Bayerl C, Bodokh I et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 2011; 13: 107-12. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003; 27: 354-66; discussion 367 Borelli C, Kunte C, Weisenseel P et al. Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol 2005; 18: 273-8. Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol 2004; 3: 542-7. Humble G, Mest D. Soft tissue augmentation using sculptra. Facial Plast Surg 2004; 20: 157-63. Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg 2009; 25: 95-9. Lombardi T, Samson J, Plantier F et al. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 2004; 33: 115-20. Moe KS, Weisman RA. Resorbable fixation in facial plastic and head and neck reconstructive surgery: an initial report on polylactic acid implants. Laryngoscope. 2001; 111: 1697-701. Greco TM, Antunes MB, Yellin SA. Injectable fillers for volume replacement in the aging face. Facial Plast Surg 2012; 28: 8-20. Woerle B, Hanke CW, Sattler G. Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 2004; 3: 385-9. Moyle GJ, Lysakova L, Brown S et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004; 5: 82-7. Carruthers A, Carey W, De Lorenzi C et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005; 31: 1591-8; discussion 1598. Narins RS, Brandt F, Leyden J et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588-95. Brady JM, Cutright DE, Miller RA, Barristone GC. Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res 1973; 7: 155-66. Lowe NJ. Optimizing poly-L-lactic acid use. J Cosmet Laser Ther 2008; 10: 43-6. Christensen L, Breiting V, Janssen M et al. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29: 34-48. Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118(Suppl): 55-63S. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005; 52: 233-9. 2001; 111 2004; 33 2009; 25 2004; 20 1993; 27 1995; 12 2005; 52 2004; 3 2005; 31 2006; 19 2003; 27 2004; 5 2011; 13 2008; 10 2012; 28 2003; 29 2011; 37 2003 2006; 118 1973; 7 2005; 29 2005; 18 Gogolewski (10.1111/ced.12499-BIB0008|ced12499-cit-0008) 1993; 27 Rzany (10.1111/ced.12499-BIB0011|ced12499-cit-0011) 2011; 13 Narins (10.1111/ced.12499-BIB0012|ced12499-cit-0012) 2003; 29 Burgess (10.1111/ced.12499-BIB0002|ced12499-cit-0002) 2005; 52 Christensen (10.1111/ced.12499-BIB0015|ced12499-cit-0015) 2005; 29 Humble (10.1111/ced.12499-BIB0023|ced12499-cit-0023) 2004; 20 Carruthers (10.1111/ced.12499-BIB0010|ced12499-cit-0010) 2005; 31 Athanasiou (10.1111/ced.12499-BIB0004|ced12499-cit-0004) 1995; 12 Brady (10.1111/ced.12499-BIB0021|ced12499-cit-0021) 1973; 7 Rotunda (10.1111/ced.12499-BIB0003|ced12499-cit-0003) 2006; 19 Greco (10.1111/ced.12499-BIB0006|ced12499-cit-0006) 2012; 28 Lemperle (10.1111/ced.12499-BIB0014|ced12499-cit-0014) 2003; 27 Lowe (10.1111/ced.12499-BIB0020|ced12499-cit-0020) 2008; 10 Woerle (10.1111/ced.12499-BIB0019|ced12499-cit-0019) 2004; 3 Rao (10.1111/ced.12499-BIB0009|ced12499-cit-0009) 2005; 31 Lacombe (10.1111/ced.12499-BIB0017|ced12499-cit-0017) 2009; 25 Lombardi (10.1111/ced.12499-BIB0005|ced12499-cit-0005) 2004; 33 10.1111/ced.12499-BIB0013|ced12499-cit-0013 Moyle (10.1111/ced.12499-BIB0022|ced12499-cit-0022) 2004; 5 Vleggaar (10.1111/ced.12499-BIB0018|ced12499-cit-0018) 2004; 3 Lam (10.1111/ced.12499-BIB0007|ced12499-cit-0007) 2006; 118 Borelli (10.1111/ced.12499-BIB0024|ced12499-cit-0024) 2005; 18 Nast (10.1111/ced.12499-BIB0001|ced12499-cit-0001) 2011; 37 Moe (10.1111/ced.12499-BIB0016|ced12499-cit-0016) 2001; 111 |
References_xml | – reference: Christensen L, Breiting V, Janssen M et al. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29: 34-48. – reference: Humble G, Mest D. Soft tissue augmentation using sculptra. Facial Plast Surg 2004; 20: 157-63. – reference: Greco TM, Antunes MB, Yellin SA. Injectable fillers for volume replacement in the aging face. Facial Plast Surg 2012; 28: 8-20. – reference: Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol 2004; 3: 542-7. – reference: Lowe NJ. Optimizing poly-L-lactic acid use. J Cosmet Laser Ther 2008; 10: 43-6. – reference: Brady JM, Cutright DE, Miller RA, Barristone GC. Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res 1973; 7: 155-66. – reference: Gogolewski S, Jovanovic M, Perren SM et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48. – reference: Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg 2009; 25: 95-9. – reference: Lombardi T, Samson J, Plantier F et al. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 2004; 33: 115-20. – reference: Woerle B, Hanke CW, Sattler G. Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 2004; 3: 385-9. – reference: Rotunda AM, Narins RS. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther 2006; 19: 151-8. – reference: Carruthers A, Carey W, De Lorenzi C et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005; 31: 1591-8; discussion 1598. – reference: Borelli C, Kunte C, Weisenseel P et al. Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol 2005; 18: 273-8. – reference: Narins RS, Brandt F, Leyden J et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588-95. – reference: Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005; 52: 233-9. – reference: Nast A, Reytan N, Hartmann V, Pathirana D et al. Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study. Dermatol Surg 2011; 37: 768-75. – reference: Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS. Applications of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 1995; 12: 475-95. – reference: Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003; 27: 354-66; discussion 367 – reference: Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118(Suppl): 55-63S. – reference: Rzany B, Bayerl C, Bodokh I et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 2011; 13: 107-12. – reference: Rao J, Chi GC, Goldman MP. Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: hylaform versus Restylane. Dermatol Surg 2005; 31: 1587-90. – reference: Moyle GJ, Lysakova L, Brown S et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004; 5: 82-7. – reference: Moe KS, Weisman RA. Resorbable fixation in facial plastic and head and neck reconstructive surgery: an initial report on polylactic acid implants. Laryngoscope. 2001; 111: 1697-701. – volume: 7 start-page: 155 year: 1973 end-page: 66 article-title: Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat publication-title: J Biomed Mater Res – volume: 118 start-page: 55 issue: Suppl year: 2006 end-page: 63S article-title: Injectable poly‐L‐lactic acid (Sculptra): technical considerations in soft‐tissue contouring publication-title: Plast Reconstr Surg – volume: 33 start-page: 115 year: 2004 end-page: 20 article-title: Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases publication-title: J Oral Pathol Med – volume: 31 start-page: 1587 year: 2005 end-page: 90 article-title: Clinical comparison between two hyaluronic acid‐derived fillers in the treatment of nasolabial folds: hylaform versus Restylane publication-title: Dermatol Surg – volume: 31 start-page: 1591 year: 2005 end-page: 8 article-title: Randomized, double‐blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane perlane and hylaform, in the treatment of nasolabial folds publication-title: Dermatol Surg – volume: 13 start-page: 107 year: 2011 end-page: 12 article-title: Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6‐month interim results of a randomized, evaluator‐blinded, intra‐individual comparison study publication-title: J Cosmet Laser Ther – volume: 18 start-page: 273 year: 2005 end-page: 8 article-title: Deep subcutaneous application of poly‐L‐lactic acid as a filler for facial lipoatrophy in HIV‐infected patients publication-title: Skin Pharmacol Physiol – volume: 20 start-page: 157 year: 2004 end-page: 63 article-title: Soft tissue augmentation using sculptra publication-title: Facial Plast Surg – volume: 19 start-page: 151 year: 2006 end-page: 8 article-title: Poly‐L‐lactic acid: a new dimension in soft tissue augmentation publication-title: Dermatol Ther – year: 2003 – volume: 3 start-page: 542 year: 2004 end-page: 7 article-title: Facial enhancement and the European experience with Sculptra (poly‐l‐lactic acid) publication-title: J Drugs Dermatol – volume: 5 start-page: 82 year: 2004 end-page: 7 article-title: A randomized open‐label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection publication-title: HIV Med. – volume: 25 start-page: 95 year: 2009 end-page: 9 article-title: Sculptra: a stimulatory filler publication-title: Facial Plast Surg – volume: 29 start-page: 34 year: 2005 end-page: 48 article-title: Adverse reactions to injectable soft tissue permanent fillers publication-title: Aesthetic Plast Surg – volume: 111 start-page: 1697 year: 2001 end-page: 701 article-title: Resorbable fixation in facial plastic and head and neck reconstructive surgery: an initial report on polylactic acid implants publication-title: Laryngoscope. – volume: 28 start-page: 8 year: 2012 end-page: 20 article-title: Injectable fillers for volume replacement in the aging face publication-title: Facial Plast Surg – volume: 3 start-page: 385 year: 2004 end-page: 9 article-title: Poly‐L‐lactic acid: a temporary filler for soft tissue augmentation publication-title: J Drugs Dermatol – volume: 27 start-page: 1135 year: 1993 end-page: 48 article-title: Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3‐hydroxybutyrate) (PHB), and poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHB/VA) publication-title: J Biomed Mater Res – volume: 10 start-page: 43 year: 2008 end-page: 6 article-title: Optimizing poly‐L‐lactic acid use publication-title: J Cosmet Laser Ther – volume: 52 start-page: 233 year: 2005 end-page: 9 article-title: Assessment of the safety and efficacy of poly‐L‐lactic acid for the treatment of HIV‐associated facial lipoatrophy publication-title: J Am Acad Dermatol – volume: 12 start-page: 475 year: 1995 end-page: 95 article-title: Applications of biodegradable lactides and glycolides in podiatry publication-title: Clin Podiatr Med Surg – volume: 27 start-page: 354 year: 2003 end-page: 66 article-title: Human histology and persistence of various injectable filler substances for soft tissue augmentation publication-title: Aesthetic Plast Surg – volume: 29 start-page: 588 year: 2003 end-page: 95 article-title: A randomized, double‐blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds publication-title: Dermatol Surg – volume: 37 start-page: 768 year: 2011 end-page: 75 article-title: Efficacy and durability of two hyaluronic acid‐based fillers in the correction of nasolabial folds: results of a prospective, randomized, double‐blind, actively controlled clinical pilot study publication-title: Dermatol Surg – volume: 27 start-page: 354 year: 2003 ident: 10.1111/ced.12499-BIB0014|ced12499-cit-0014 article-title: Human histology and persistence of various injectable filler substances for soft tissue augmentation publication-title: Aesthetic Plast Surg doi: 10.1007/s00266-003-3022-1 – volume: 33 start-page: 115 year: 2004 ident: 10.1111/ced.12499-BIB0005|ced12499-cit-0005 article-title: Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases publication-title: J Oral Pathol Med doi: 10.1111/j.1600-0714.2004.00194.x – volume: 31 start-page: 1587 year: 2005 ident: 10.1111/ced.12499-BIB0009|ced12499-cit-0009 article-title: Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: hylaform versus Restylane publication-title: Dermatol Surg doi: 10.2310/6350.2005.31245 – volume: 3 start-page: 385 year: 2004 ident: 10.1111/ced.12499-BIB0019|ced12499-cit-0019 article-title: Poly-L-lactic acid: a temporary filler for soft tissue augmentation publication-title: J Drugs Dermatol – volume: 3 start-page: 542 year: 2004 ident: 10.1111/ced.12499-BIB0018|ced12499-cit-0018 article-title: Facial enhancement and the European experience with Sculptra (poly-l-lactic acid) publication-title: J Drugs Dermatol – volume: 18 start-page: 273 year: 2005 ident: 10.1111/ced.12499-BIB0024|ced12499-cit-0024 article-title: Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients publication-title: Skin Pharmacol Physiol doi: 10.1159/000087608 – volume: 37 start-page: 768 year: 2011 ident: 10.1111/ced.12499-BIB0001|ced12499-cit-0001 article-title: Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study publication-title: Dermatol Surg – volume: 27 start-page: 1135 year: 1993 ident: 10.1111/ced.12499-BIB0008|ced12499-cit-0008 article-title: Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA) publication-title: J Biomed Mater Res doi: 10.1002/jbm.820270904 – volume: 118 start-page: 55 issue: Suppl year: 2006 ident: 10.1111/ced.12499-BIB0007|ced12499-cit-0007 article-title: Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring publication-title: Plast Reconstr Surg doi: 10.1097/01.prs.0000234612.20611.5a – volume: 29 start-page: 588 year: 2003 ident: 10.1111/ced.12499-BIB0012|ced12499-cit-0012 article-title: A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds publication-title: Dermatol Surg – volume: 111 start-page: 1697 year: 2001 ident: 10.1111/ced.12499-BIB0016|ced12499-cit-0016 article-title: Resorbable fixation in facial plastic and head and neck reconstructive surgery: an initial report on polylactic acid implants publication-title: Laryngoscope. doi: 10.1097/00005537-200110000-00005 – volume: 25 start-page: 95 year: 2009 ident: 10.1111/ced.12499-BIB0017|ced12499-cit-0017 article-title: Sculptra: a stimulatory filler publication-title: Facial Plast Surg doi: 10.1055/s-0029-1220648 – ident: 10.1111/ced.12499-BIB0013|ced12499-cit-0013 – volume: 10 start-page: 43 year: 2008 ident: 10.1111/ced.12499-BIB0020|ced12499-cit-0020 article-title: Optimizing poly-L-lactic acid use publication-title: J Cosmet Laser Ther doi: 10.1080/14764170701840074 – volume: 31 start-page: 1591 year: 2005 ident: 10.1111/ced.12499-BIB0010|ced12499-cit-0010 article-title: Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane perlane and hylaform, in the treatment of nasolabial folds publication-title: Dermatol Surg doi: 10.2310/6350.2005.31246 – volume: 13 start-page: 107 year: 2011 ident: 10.1111/ced.12499-BIB0011|ced12499-cit-0011 article-title: Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study publication-title: J Cosmet Laser Ther doi: 10.3109/14764172.2011.571699 – volume: 28 start-page: 8 year: 2012 ident: 10.1111/ced.12499-BIB0006|ced12499-cit-0006 article-title: Injectable fillers for volume replacement in the aging face publication-title: Facial Plast Surg doi: 10.1055/s-0032-1305786 – volume: 29 start-page: 34 year: 2005 ident: 10.1111/ced.12499-BIB0015|ced12499-cit-0015 article-title: Adverse reactions to injectable soft tissue permanent fillers publication-title: Aesthetic Plast Surg doi: 10.1007/s00266-004-0113-6 – volume: 12 start-page: 475 year: 1995 ident: 10.1111/ced.12499-BIB0004|ced12499-cit-0004 article-title: Applications of biodegradable lactides and glycolides in podiatry publication-title: Clin Podiatr Med Surg doi: 10.1016/S0891-8422(23)00954-0 – volume: 52 start-page: 233 year: 2005 ident: 10.1111/ced.12499-BIB0002|ced12499-cit-0002 article-title: Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2004.08.056 – volume: 19 start-page: 151 year: 2006 ident: 10.1111/ced.12499-BIB0003|ced12499-cit-0003 article-title: Poly-L-lactic acid: a new dimension in soft tissue augmentation publication-title: Dermatol Ther doi: 10.1111/j.1529-8019.2006.00069.x – volume: 7 start-page: 155 year: 1973 ident: 10.1111/ced.12499-BIB0021|ced12499-cit-0021 article-title: Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat publication-title: J Biomed Mater Res doi: 10.1002/jbm.820070204 – volume: 5 start-page: 82 year: 2004 ident: 10.1111/ced.12499-BIB0022|ced12499-cit-0022 article-title: A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection publication-title: HIV Med. doi: 10.1111/j.1468-1293.2004.00190.x – volume: 20 start-page: 157 year: 2004 ident: 10.1111/ced.12499-BIB0023|ced12499-cit-0023 article-title: Soft tissue augmentation using sculptra publication-title: Facial Plast Surg doi: 10.1055/s-2004-861758 |
SSID | ssj0013175 |
Score | 2.1934028 |
Snippet | Summary
Background
Hyaluronic acid (HA) fillers and poly‐L‐lactic acid (PLA) fillers are frequently used to correct facial wrinkles.
Aim
To compare the... Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. To compare the efficacy and safety of a novel... Summary Background Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. Aim To compare the... Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles.BACKGROUNDHyaluronic acid (HA) fillers and... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 129 |
SubjectTerms | Adult Aged Cosmetic Techniques - adverse effects Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Female Humans Hyaluronic Acid - administration & dosage Hyaluronic Acid - adverse effects Injections - adverse effects Lactic Acid - administration & dosage Lactic Acid - adverse effects Male Middle Aged Nasolabial Fold Polyesters Polymers - administration & dosage Polymers - adverse effects Skin Aging - drug effects Viscosupplements - administration & dosage Viscosupplements - adverse effects |
Title | Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study |
URI | https://api.istex.fr/ark:/67375/WNG-RS5PC66P-F/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fced.12499 https://www.ncbi.nlm.nih.gov/pubmed/25319932 https://www.proquest.com/docview/1655230853 https://www.proquest.com/docview/1657317012 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWqVkJseD9SSmUQQizIaGLHTgyrdjpDhWhVFSq6QIr8ihiaJlVmRmK64hP4Fj6JL-HaeZSiIiEWkaL4Orbje-0T-95jhJ5JIuJIExGqSJswNnwYKs5IOITJTuqc2GbBbW-f7x7Fb4_Z8Qp63cXCNPwQ_YKbsww_XjsDl2r2m5Frawbu5GQXvOd8tRwgOiQXOwiRJ9n1JIhc0LRlFXJePH3OS3PRmvusX68Cmpdxq594JjfRp67Kjb_JyWAxVwN9_geb43-26Ra60QJSvNVo0G20Yss76Npeu-V-F_0YO5IJqZdYlgbPZG7nS1zleFp-8V5cJXZLufisKpY_v31_B1fh466w1FODOxf3RujzUhYLT8bbpAJgBom6bl8Eby0l2IJ0USyQWJhXWGKYTE11Oj235iVuucmrGopRhWN6hIf6gsAce7bce-hoMv4w2g3bgx5CTUUkwognkuWMiCEzNKdUuQgkoS0XxiqVsxRQkbBEJSZNraZEpQbGEiW4opAxtvQ-Wi2r0j5EmAxpnLitRmZ5rKIcNI5EhhsuuaVSpgF60XV5plsWdHcYR5F1f0PQB5nvgwA97UXPGuqPq4See73pJWR94nzlEpZ93H-THb5nByPOD7JJgDY6xcraYWKWRZy5VXmATAF60ieDgbtdG1naauFlEupY80mAHjQK2RdG3AgKCBxa5dXq7_XMRuMdf7P-76KP0HWAh6zxuNtAq_N6YR8DBJurTbS2tb2zPdn0NvcLlE0x9Q |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbGJgE3_MMKAwxCiAtSNXbsxIgbVFoKtNU0NrEbFPkvWllIpq6V6K54BJ6FR-JJOHZ-xtCQEBeRovgkTuJzfD4fH39G6IkkIgo1EYEKtQkiw3uB4owEPXB2UmfEVgG3yZSP9qJ3-2x_Db1s1sJU_BBtwM1Zhu-vnYG7gPRvVq6t6bqtk8UFtOF29PYDqh1yOocQeppdT4PIBU1qXiGXx9PeesYbbbgf-_U8qHkWuXrXM7yKPjUvXWWcHHaXC9XVJ3_wOf7vV11DV2pMil9VSnQdrdniBro4qWfdb6IfA8czIfUKy8LgY5nZxQqXGZ4Vn30iV4FdNBcflfnq57fvYzhyv_QKSz0zuMlyr4QOVjJfej7eqhQwM0jM5_WD4KmFBHOQbiELFObmBZYY_Kkpv8xOrHmOa3rycg7VqNyRPcJFfcphjj1h7i20Nxzs9kdBvddDoKkIRRDyWLKMEdFjhmaUKrcISWjLhbFKZSwBYCQsUbFJEqspUYmB7kQJrijcGFl6G60XZWE3ESY9GsVutpFZHqkwA6UjoeGGS26plEkHPWvaPNU1EbrbjyNPmwERtEHq26CDHreiRxX7x3lCT73itBJyfujS5WKWfpy-SXc-sO0-59vpsIO2Gs1K657iOA05c4F5QE0d9KgtBht3EzeysOXSy8TUEeeTDrpTaWRbGXGdKIBw-CqvV39_z7Q_eO1P7v676EN0abQ7Gafjt9P399BlQIusSsDbQuuL-dLeB0S2UA-84f0C4XI0ng |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVKK1VsyhsGChiEEAsySuzYE8MKzYMC7WhUqOgCKfIr6tCQjKYzEtMVn8C38El8CdfOoxQVCbGIFMXXsR3f63tiXx8j9EQSEUeaiEBF2gSx4WGgOCNBCM5O6ozYasJtb8x3DuK3h-xwDb1s9sJU_BDthJuzDD9eOwOfmew3I9fWdN3JyeIS2oh5mDiVHuyTsyWEyLPsehZELmhS0wq5MJ426zlntOG-69eLkOZ54Oo9z-gK-tTUuQo4Oe4uF6qrT_-gc_zPRl1FWzUixa8qFbqG1mxxHW3u1WvuN9CPoWOZkHqFZWHwiczsYoXLDE-Lzz6Mq8BuLhfPynz189v3Xbhyv_EKSz01uIlxr4SOVjJfejbeKhUQM0jM5_WL4K2FBGOQbhsLJObmBZYYvKkpv0xPrXmOa3Lycg7FqNxRPcJDfcZgjj1d7k10MBp-6O8E9UkPgaYiEkHEe5JljIiQGZpRqtwWJKEtF8YqlbEEYJGwRPVMklhNiUoMDCZKcEUhY2zpLbRelIW9gzAJadxza43M8lhFGagciQw3XHJLpUw66FnT5amuadDdaRx52vwOQR-kvg866HErOqu4Py4Seur1ppWQ82MXLNdj6cfx63T_PZv0OZ-kow7abhQrrceJkzTizE3LA2bqoEdtMli4W7aRhS2XXqZHHW0-6aDblUK2hRE3hAIEh1Z5tfp7PdP-cOBv7v676EO0ORmM0t0343f30GWAiqyKvttG64v50t4HOLZQD7zZ_QJIlzNW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+safety+of+injection+with+poly-L-lactic+acid+compared+with+hyaluronic+acid+for+correction+of+nasolabial+fold%3A+a+randomized%2C+evaluator-blinded%2C+comparative+study&rft.jtitle=Clinical+and+experimental+dermatology&rft.au=Hyun%2C+M+Y&rft.au=Lee%2C+Y&rft.au=No%2C+Y+A&rft.au=Yoo%2C+K+H&rft.date=2015-03-01&rft.eissn=1365-2230&rft.volume=40&rft.issue=2&rft.spage=129&rft_id=info:doi/10.1111%2Fced.12499&rft_id=info%3Apmid%2F25319932&rft.externalDocID=25319932 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-6938&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-6938&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-6938&client=summon |